L3VLUP
ProSign in
← Glenview Capital Management LLC, its record

Glenview Capital Management LLC and Capital Research Global Investors: where the books meet

At Q2 2026, 14% of the two 13F books was the same, across 18 stocks both listed, against 5.1% at Q2 2013. Overlap is the smaller of each shared stock’s two weights, added up: the part of one book that could be swapped for the other’s without a trade.

Overlap by quarter
0%7%14%Q2 2013: 5.1%, 14 in bothQ3 2013: 6.3%, 16 in bothQ4 2013: 6.4%, 15 in bothQ1 2014: 6.1%, 16 in both14Q2 2014: 4.3%, 15 in bothQ3 2014: 5.2%, 18 in bothQ4 2014: 4.7%, 17 in bothQ1 2015: 6.3%, 18 in both15Q2 2015: 8.4%, 19 in bothQ3 2015: 8.0%, 20 in bothQ4 2015: 7.0%, 14 in bothQ1 2016: 5.7%, 10 in both16Q2 2016: 6.7%, 14 in bothQ3 2016: 6.7%, 14 in bothQ4 2016: 8.2%, 15 in bothQ1 2017: 9.1%, 16 in both17Q2 2017: 8.3%, 16 in bothQ3 2017: 8.7%, 20 in bothQ4 2017: 5.5%, 18 in bothQ1 2018: 5.5%, 21 in both18Q2 2018: 6.1%, 17 in bothQ3 2018: 7.3%, 20 in bothQ4 2018: 7.1%, 17 in bothQ1 2019: 7.8%, 14 in both19Q2 2019: 7.9%, 14 in bothQ3 2019: 7.0%, 17 in bothQ4 2019: 7.7%, 19 in bothQ1 2020: 5.4%, 16 in both20Q2 2020: 3.0%, 14 in bothQ3 2020: 2.1%, 14 in bothQ4 2020: 3.8%, 19 in bothQ1 2021: 6.7%, 14 in both21Q2 2021: 7.0%, 16 in bothQ3 2021: 5.0%, 17 in bothQ4 2021: 4.0%, 13 in bothQ1 2022: 4.6%, 12 in both22Q2 2022: 5.1%, 13 in bothQ3 2022: 5.5%, 15 in bothQ4 2022: 2.6%, 10 in bothQ1 2023: 2.5%, 10 in both23Q2 2023: 0.5%, 5 in bothQ3 2023: 5.0%, 11 in bothQ4 2023: 4.9%, 7 in bothQ1 2024: 3.6%, 6 in both24Q2 2024: 2.6%, 3 in bothQ3 2024: 3.0%, 4 in bothQ4 2024: 4.4%, 4 in bothQ1 2025: 5.6%, 7 in both25Q2 2025: 7.7%, 11 in bothQ3 2025: 5.7%, 16 in bothQ4 2025: 7.2%, 16 in bothQ1 2026: 11%, 15 in both26Q2 2026: 14%, 18 in both
  • Q2 2013: 5.1%, 14 in both
  • Q3 2013: 6.3%, 16 in both
  • Q4 2013: 6.4%, 15 in both
  • Q1 2014: 6.1%, 16 in both
  • Q2 2014: 4.3%, 15 in both
  • Q3 2014: 5.2%, 18 in both
  • Q4 2014: 4.7%, 17 in both
  • Q1 2015: 6.3%, 18 in both
  • Q2 2015: 8.4%, 19 in both
  • Q3 2015: 8.0%, 20 in both
  • Q4 2015: 7.0%, 14 in both
  • Q1 2016: 5.7%, 10 in both
  • Q2 2016: 6.7%, 14 in both
  • Q3 2016: 6.7%, 14 in both
  • Q4 2016: 8.2%, 15 in both
  • Q1 2017: 9.1%, 16 in both
  • Q2 2017: 8.3%, 16 in both
  • Q3 2017: 8.7%, 20 in both
  • Q4 2017: 5.5%, 18 in both
  • Q1 2018: 5.5%, 21 in both
  • Q2 2018: 6.1%, 17 in both
  • Q3 2018: 7.3%, 20 in both
  • Q4 2018: 7.1%, 17 in both
  • Q1 2019: 7.8%, 14 in both
  • Q2 2019: 7.9%, 14 in both
  • Q3 2019: 7.0%, 17 in both
  • Q4 2019: 7.7%, 19 in both
  • Q1 2020: 5.4%, 16 in both
  • Q2 2020: 3.0%, 14 in both
  • Q3 2020: 2.1%, 14 in both
  • Q4 2020: 3.8%, 19 in both
  • Q1 2021: 6.7%, 14 in both
  • Q2 2021: 7.0%, 16 in both
  • Q3 2021: 5.0%, 17 in both
  • Q4 2021: 4.0%, 13 in both
  • Q1 2022: 4.6%, 12 in both
  • Q2 2022: 5.1%, 13 in both
  • Q3 2022: 5.5%, 15 in both
  • Q4 2022: 2.6%, 10 in both
  • Q1 2023: 2.5%, 10 in both
  • Q2 2023: 0.5%, 5 in both
  • Q3 2023: 5.0%, 11 in both
  • Q4 2023: 4.9%, 7 in both
  • Q1 2024: 3.6%, 6 in both
  • Q2 2024: 2.6%, 3 in both
  • Q3 2024: 3.0%, 4 in both
  • Q4 2024: 4.4%, 4 in both
  • Q1 2025: 5.6%, 7 in both
  • Q2 2025: 7.7%, 11 in both
  • Q3 2025: 5.7%, 16 in both
  • Q4 2025: 7.2%, 16 in both
  • Q1 2026: 11%, 15 in both
  • Q2 2026: 14%, 18 in both

Only quarters both managers filed. Where either filing has more positions than are read each quarter, a stock both hold below that range is not counted, so the figure is a floor.

What the overlap is made of, Q2 2026

Stocks both listed, by the smaller of the two weights. A weight is the stock’s share of that manager’s reported book, which says how large the position is, not how strongly it is held.

StockGlenview Capital Management LLCCapital Research Global Investors
Amazon Com Inc(AMZN)5.5%Added4.0%Added
Facebook Inc(META)3.7%Added3.1%Added
Uber Technologies Inc(UBER)2.4%Added1.3%Added
Eli Lilly & Co(LLY)1.3%New3.5%Trimmed
Cisco Sys Inc(CSCO)0.9%Added1.1%Added
Applied Matls Inc(AMAT)0.9%Trimmed2.2%Trimmed
Abbvie Inc(ABBV)0.7%New1.1%Trimmed
CVS Health Corp(CVS)9.1%Trimmed0.4%Added
Thermo Fisher Scientific Inc(TMO)5.7%Added0.3%Trimmed
Danaher Corp Del(DHR)4.0%Added0.3%Added
Baker Hughes Company(BKR)0.5%Added0.2%Added
G0593m107(AZN)0.6%New0.1%Trimmed
Advanced Micro Devices Inc(AMD)3.2%Trimmedunder 0.1%Trimmed
Boston Scientific Corp(BSX)under 0.1%Newunder 0.1%Added
Humana Inc(HUM)1.8%Trimmedunder 0.1%Added
United Airls HLDGS Inc(UAL)1.2%Trimmedunder 0.1%Added
Cigna Corp New(CI)2.1%Trimmedunder 0.1%Trimmed
Bio-techne Corp(TECH)under 0.1%Trimmedunder 0.1%Trimmed

Moved different ways in Q2 2026

Stocks one manager started or added to while the other trimmed or sold out, between the same two quarter ends. A 13F shows the quarter ends, never when in between anything was bought or sold, or why.

  • Eli Lilly & Co(LLY)Glenview Capital Management LLC started; Capital Research Global Investors trimmed
  • Abbvie Inc(ABBV)Glenview Capital Management LLC started; Capital Research Global Investors trimmed
  • CVS Health Corp(CVS)Glenview Capital Management LLC trimmed; Capital Research Global Investors added
  • Thermo Fisher Scientific Inc(TMO)Glenview Capital Management LLC added; Capital Research Global Investors trimmed
  • G0593m107(AZN)Glenview Capital Management LLC started; Capital Research Global Investors trimmed
  • Humana Inc(HUM)Glenview Capital Management LLC trimmed; Capital Research Global Investors added
  • United Airls HLDGS Inc(UAL)Glenview Capital Management LLC trimmed; Capital Research Global Investors added
Glenview Capital Management LLC: the recordCapital Research Global Investors: the record

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More